Fiagon

Fiagon is a medical technology company founded in 2007 by Dr. Timo Kruger and Dr. Dirk Mucha. The company specializes in electromagnetic surgical navigation systems that enhance patient outcomes by providing accurate and integrated navigation solutions. Its primary focus is on ENT (ear, nose, and throat) surgery, with expansions into oral and maxillofacial surgery, neurosurgery, and spine surgery. The company's core innovation is its proprietary Flexsensor technology, which allows for real-time tracking of surgical instruments without calibration. This technology improves surgical precision and safety during procedures like functional endoscopic sinus surgery (FESS). Fiagon's flagship product, the Cube 4D navigation system, features VirtuEye® one-click photoregistration, and the company also offers navigable sinuplasty balloons (Vensure®) designed for minimally invasive interventions. Fiagon's products have received regulatory approval, including FDA clearance for their ENT platform in 2014, and are used in over 40 countries worldwide. In 2022, Fiagon's assets were acquired by Hemostasis, which aims to integrate Fiagon's navigation technology with its own ENT treatment products. The company is headquartered in Hennigsdorf, Germany, with a North American office in Austin, Texas.

• Employees 45
• Founded 2007
• Total Funding $7500000